140 results on '"Kauffman, Kevin"'
Search Results
2. NAD depletion mediates cytotoxicity in human neurons with autophagy deficiency
3. Identification of Novel Fibrosis Modifiers by In Vivo siRNA Silencing
4. Antibodies Targeting Human or Mouse VSIG4 Repolarize Tumor-Associated Macrophages Providing the Potential of Potent and Specific Clinical Anti-Tumor Response Induced across Multiple Cancer Types.
5. In Vivo RNAi-Mediated eIF3m Knockdown Affects Ribosome Biogenesis and Transcription but Has Limited Impact on mRNA-Specific Translation
6. 1205 Surmounting conventional cell therapy limitationsvia in situCAR therapy using oRNA™ lipid nanoparticles
7. Supplementary Figure 1 from PSGL-1 Blockade Induces Classical Activation of Human Tumor-associated Macrophages
8. FIGURE 3 from PSGL-1 Blockade Induces Classical Activation of Human Tumor-associated Macrophages
9. FIGURE 2 from PSGL-1 Blockade Induces Classical Activation of Human Tumor-associated Macrophages
10. Supplementary Table 3 from PSGL-1 Blockade Induces Classical Activation of Human Tumor-associated Macrophages
11. FIGURE 5 from PSGL-1 Blockade Induces Classical Activation of Human Tumor-associated Macrophages
12. Supplementary Figure 9 from PSGL-1 Blockade Induces Classical Activation of Human Tumor-associated Macrophages
13. FIGURE 6 from PSGL-1 Blockade Induces Classical Activation of Human Tumor-associated Macrophages
14. Supplementary Table 1 from PSGL-1 Blockade Induces Classical Activation of Human Tumor-associated Macrophages
15. Supplementary Figure 2 from PSGL-1 Blockade Induces Classical Activation of Human Tumor-associated Macrophages
16. Supplementary Figure 4 from PSGL-1 Blockade Induces Classical Activation of Human Tumor-associated Macrophages
17. Supplementary Figure 6 from PSGL-1 Blockade Induces Classical Activation of Human Tumor-associated Macrophages
18. Supplementary Figure 5 from PSGL-1 Blockade Induces Classical Activation of Human Tumor-associated Macrophages
19. Supplementary Figure 7 from PSGL-1 Blockade Induces Classical Activation of Human Tumor-associated Macrophages
20. Supplementary Figure 3 from PSGL-1 Blockade Induces Classical Activation of Human Tumor-associated Macrophages
21. Supplementary Table 2 from PSGL-1 Blockade Induces Classical Activation of Human Tumor-associated Macrophages
22. Supplementary Figure 8 from PSGL-1 Blockade Induces Classical Activation of Human Tumor-associated Macrophages
23. FIGURE 4 from PSGL-1 Blockade Induces Classical Activation of Human Tumor-associated Macrophages
24. FIGURE 1 from PSGL-1 Blockade Induces Classical Activation of Human Tumor-associated Macrophages
25. PSGL-1 Blockade Induces Classical Activation of Human Tumor-Associated Macrophages
26. Barcoded nanoparticles for high throughput in vivo discovery of targeted therapeutics
27. Efficacy and immunogenicity of unmodified and pseudouridine-modified mRNA delivered systemically with lipid nanoparticles in vivo
28. Materials for non-viral intracellular delivery of messenger RNA therapeutics
29. Cancer Nanotherapeutics in Clinical Trials
30. Uremic Toxin Indoxyl Sulfate Promotes Proinflammatory Macrophage Activation Via the Interplay of OATP2B1 and Dll4-Notch Signaling: Potential Mechanism for Accelerated Atherogenesis in Chronic Kidney Disease
31. 1222 In situCAR therapy using oRNA™ lipid nanoparticles regresses tumors in mice
32. NAD Depletion Mediates Cytotoxicity in Human Neurons With Autophagy Deficiency
33. Abstract P107: PSGL-1 blocking antibodies repolarize tumor associated macrophages, reduce suppressive myeloid populations and induce inflammation in the tumor microenvironment, leading to suppression of tumor growth
34. 877 PSGL-1 blocking antibodies repolarize tumor associated macrophages, reduce suppressive myeloid populations and induce inflammation in the tumor microenvironment, leading to suppression of tumor growth
35. Autophagy promotes cell survival by maintaining NAD(H) levels
36. Hexachromatic bioinspired camera for image-guided cancer surgery
37. I Knew That!
38. 862 Targeting PSGL-1, a novel macrophage checkpoint, repolarizes suppressive macrophages, induces an inflammatory tumor microenvironment, and suppresses tumor growth
39. PSGL-1 is a novel macrophage checkpoint in immuno-oncology.
40. SIP Shear Walls: Cyclic Performance of High-Aspect-Ratio Segments and Perforated Walls
41. Endothelial TGF-β signalling drives vascular inflammation and atherosclerosis
42. Gene Delivery: Inhaled Nanoformulated mRNA Polyplexes for Protein Production in Lung Epithelium (Adv. Mater. 8/2019)
43. Inhaled Nanoformulated mRNA Polyplexes for Protein Production in Lung Epithelium
44. Customizable Lipid Nanoparticle Materials for the Delivery of siRNAs and mRNAs
45. Optimization of a Degradable Polymer–Lipid Nanoparticle for Potent Systemic Delivery of mRNA to the Lung Endothelium and Immune Cells
46. A 1280 by 720 by 3, 250 mW, 24 fps Hexachromatic Imager for Near-Infrared Fluorescence Image-Guided Surgery
47. Live Demonstration: A 1280 by 720 by 3, 250 mW, 24 fps Hexachromatic Imager for Near-Infrared Fluorescence Image-Guided Surgery
48. Hexachromatic imager for near-infrared fluorescence image-guided surgery (Conference Presentation)
49. Rapid, Single-Cell Analysis and Discovery of Vectored mRNA Transfection In Vivo with a loxP-Flanked tdTomato Reporter Mouse
50. A Six-channel Multispectral Imager for Simultaneous In Vivo Imaging of Multiple Near-Infrared Fluorescent Markers
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.